Can a simple infusion shield your kidneys during robotic cancer surgery?
NCT ID NCT06408597
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two drugs, mannitol and nitroglycerin, given during robotic prostate or bladder surgery to prevent acute kidney injury. The surgery can reduce blood flow to the kidneys, and these drugs may help protect them. 90 adults with normal or mildly reduced kidney function are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mannitol or nitroglycerin
- What this could lead to
- If it works, this could point toward a simple way to protect kidneys during robotic surgery, reducing complications.
- What could go wrong
- This is a small, early-stage trial with only 90 participants. It may not show a clear benefit, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University Hospitals
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a Bag-Like device pull bladder tumors out whole?
- A second look: MRI screening may spot hidden prostate cancers
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Can precision protons spare the bowel in prostate cancer?